


Dr. Bijal Shah, MD
book an appointment

Dr. Bijal Shah, MD
Hematology & Oncology
Dr. Bijal Shah, MD is a hematologist oncologist in Tampa, FL. Dr. Shah has extensive experience in Lymphatic System Disorders. He is affiliated with Moffitt Cancer Center Magnolia Campus. He is accepting new patients and telehealth appointments.
Locations
Moffitt Cancer Center, Magnolia Campus
At a Glance
- Areas of Expertise • Dr. Shah specializes in the areas of Hematology & Medical Oncology. See board certifications
- Explains Conditions Well • Patients said this doctor explains conditions well. See reviews
- Offers Telehealth • This doctor offers telehealth appointments. Call the office to schedule an appointment.
- Trustworthy • Patients said this doctor is trustworthy. See reviews
More Hematology Specialists at Moffitt Cancer Center
Experience Check
Search for experience in a specific area
Dr. Shah's Reviews
Likelihood to recommend Dr. Shah
5 star | 88% | 88% |
4 star | 6% | 6% |
3 star | 0% | 0% |
2 star | 0% | 0% |
1 star | 6% | 6% |
Your trust is our top concern.
We strive to keep reviews honest, trustworthy, and fair.Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Trusted the provider's decisions
- Office environment
- Difficult to schedule appointment
- Didn't listen or answer questions
- Didn't explain conditions well
- Staff wasn't friendly
- Appointment was rushed
- Didn't trust the provider's decisions
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
- Wait times
- Office environment
- Appointment scheduling
- Listened & answered questions
- Explained conditions well
- Staff friendliness
- Appointment wasn't rushed
- Trusted the provider's decisions
Leave a review
How was your experience with Dr. Shah?Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Shah to family and friends is 4.6875 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
care philosophy
Dr Bijal Shah is an Associate Member in the Department of Malignant Hematology. Dr Shah's primary clinical interests are in Non-Hodgkin Lymphomas (particularly mantle cell lymphoma) and Acute Lymphoblastic Leukemia. As an internist and pediatrician,...read morebiography
Dr. Bijal Shah is an Associate Member in the Department of Malignant Hematology. Dr. Shah's primary clinical interests are in Non-Hodgkin Lymphomas (particularly mantleHematology & Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of South Florida
Fellowship HospitalDuke University
Residency Hospital
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkTwo-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study, 2022-12-10
MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas, 2021-01-14